Q4 2024 Earnings Call Transcript May 29, 2025 Roivant Sciences Ltd. misses on earnings expectations. Reported EPS is $-0.22 ...

We recently published a list of While Wall Street Naps, These 10 Stocks Run Wild. In this article, we are going to take a ...

Roivant Sciences Ltd (NASDAQ:ROIV) is set to release its Q4 2025 earnings on May 29, 2025. The consensus estimate for Q4 2025 ...

Roivant Sciences Ltd (ROIV) showcases robust cash reserves and strategic share repurchases while navigating legal uncertainties and competitive pressures.

Roivant Sciences (NASDAQ:ROIV) will release its quarterly earnings report on Thursday, 2025-05-29. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Roivant ...

Roivant Sciences Ltd. (ROIV) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.23 per share a year ago.

Roivant Sciences (NASDAQ:ROIV) shares are trading down by -40% across the past 12 months, and down 24% since the company joined the Nasdaq via a merger with the Special Purpose Acquisition Company ...

Roivant Sciences exhibits a strong financial outlook, backed by its substantial cash position, strategic acquisitions, and efficient R&D expense management. The company's innovative drug pipeline ...

Roivant Sciences (NASDAQ:ROIV) has observed the following analyst ratings within the last quarter: These 7 analysts have an average price target of $16.57 versus the current price of Roivant ...

Analysts anticipate Roivant Sciences to report an earnings per share (EPS) of $-0.16. The announcement from Roivant Sciences is eagerly anticipated, with investors seeking news of surpassing estimates ...